Citadel Advisors
RVMD icon

Citadel Advisors’s Revolution Medicines RVMD Stock Holding History

Citadel Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32M Buy
329,500
+316,900
+2,515% +$32M 0.01% 1793
2025
Q4 		$1M Sell
12,600
-143,000
-92% -$9.38M ﹤0.01% 7381
2025
Q3 		$7.27M Buy
155,600
+23,300
+18% +$912K ﹤0.01% 3729
2025
Q2 		$4.87M Buy
132,300
+27,200
+26% +$1.04M ﹤0.01% 4158
2025
Q1 		$3.72M Sell
105,100
-29,200
-22% -$1.19M ﹤0.01% 4382
2024
Q4 		$5.87M Buy
134,300
+18,900
+16% +$954K ﹤0.01% 3707
2024
Q3 		$5.23M Buy
115,400
+103,300
+854% +$4.5M ﹤0.01% 3863
2024
Q2 		$470K Buy
12,100
+1,100
+10% +$41.1K ﹤0.01% 8179
2024
Q1 		$355K Sell
11,000
-8,000
-42% -$237K ﹤0.01% 9123
2023
Q4 		$545K Buy
19,000
+4,100
+28% +$98.5K ﹤0.01% 7911
2023
Q3 		$412K Buy
14,900
+6,600
+80% +$196K ﹤0.01% 8497
2023
Q2 		$222K Hold
8,300
– – ﹤0.01% 9656
2023
Q1 		$180K Buy
8,300
+3,000
+57% +$73.9K ﹤0.01% 10363
2022
Q4 		$126K Buy
+5,300
New +$113K ﹤0.01% 10868
2022
Q1 		– Sell
-11,200
Closed -$282K – 14444
2021
Q4 		$282K Sell
11,200
-7,800
-41% -$220K ﹤0.01% 11057
2021
Q3 		$523K Buy
19,000
+11,700
+160% +$341K ﹤0.01% 9757
2021
Q2 		$232K Buy
+7,300
New +$255K ﹤0.01% 11840

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Citadel Advisors's RVMD Position: Q1 2026 in Review

Citadel Advisors reduced its Revolution Medicines (RVMD) stake by 69% in Q1 2026, selling an estimated $91.1M and leaving 400,053 shares worth $38.9M. The position accounts for 0.01% of the portfolio, ranked #1594.

Citadel Advisors first reported a position in RVMD in Q1 2020 and has held it in 24 quarters since. The position peaked at $104M in Q4 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Citadel Advisors held 400,053 shares of Revolution Medicines worth $38.9M as of Q1 2026.
  • Citadel Advisors sold 902,308 Revolution Medicines shares in Q1 2026, an estimated $91.1M.
  • Revolution Medicines made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1594 holding.
  • Citadel Advisors first reported a position in Revolution Medicines in Q1 2020 and has held it in 24 quarters since.
  • Citadel Advisors's Revolution Medicines position peaked at $104M in Q4 2025.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.